The Navy Medical Readiness Logistics Command Detachment Fort Detrick has a requirement for the Drug Demand Reduction Program, for the initial (screen) immunoassay for the detection of 6-Acetylmorphine Immunoassay Reagent Kits in urine > 10 ng/mL.
ID: N0018924RZ162Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE NAVYNAVSUP FLT LOG CTR NORFOLKNORFOLK, VA, 23511-3392, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/d84feb886fdf451098fa8b4036f9b57d/view
Timeline
    Description

    The Department of Defense, specifically the Navy Medical Readiness Logistics Command Detachment Fort Detrick, is seeking proposals for the procurement of FDA-approved Immunoassay Reagent Kits designed for the detection of 6-acetylmorphine (6AM) in urine samples. The contract requires vendors to provide reagent kits compatible with Beckman Coulter AU5800 series analyzers, capable of conducting up to 500,000 tests per month over a five-year period, while adhering to stringent FDA and quality management documentation standards. This procurement is critical for the Drug Demand Reduction Program, ensuring accurate and reliable drug testing within the Department of Defense. Interested vendors must submit technical documentation by October 25, 2024, with final quotes due by November 22, 2024. For further inquiries, contact James Berghaier at 215-697-2022 or via email at james.berghaier@navy.mil.

    Point(s) of Contact
    James Berghaier 215-697-2022 James.W.Berghaier.civ@us.navy.mil
    james.berghaier@navy.mil
    Gerald Bowne
    gerald.l.bowne.civ@us.navy.mil
    Files
    Title
    Posted
    N0018924RZ162.pdf
    This document pertains to a Request for Proposal (RFP) issued by the Navy for the procurement of FDA-approved Immunoassay Reagent Kits designed to detect 6-acetylmorphine (6AM) in urine samples. The contract emphasizes the necessity for robust documentation including FDA and ISO certifications, product specifications, and compliance attestations from Original Equipment Manufacturers (OEM) or authorized distributors. The proposal timeline requires submission of technical documentation by October 25, 2024, with final quotes due by November 22, 2024. The statement of work outlines requirements for sensitivity, specificity, and performance in conjunction with Beckman Coulter AU5800 series analyzers. Contractors must ensure monthly delivery capacity of reagents to facilitate up to 500,000 tests monthly, highlighting the operational scale. Quality assurance standards must align with FDA regulations and involve thorough testing, calibration, and compliance reporting. The contract prioritizes small business participation, particularly service-disabled veteran-owned and women-owned businesses. The document’s structure delineates solicitation guidelines, submission processes, evaluation criteria, and compliance expectations, reinforcing the government's commitment to maintaining high safety and quality standards in procurement.
    Similar Opportunities
    6550--MPLS - Toxicology Drugs of Abuse Supplies Reagents, Calibrators, and Controls for Assays - Solicitation
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the acquisition of FDA-approved CEDIA and DRI drugs of abuse reagents, calibrators, and controls specifically for assays related to Oxycodone, Ecstasy, Heroin (6MAM), and Hydrocodone. This procurement is a Brand Name Only requirement, exclusively for products manufactured by Microgenics Corporation, to ensure compliance with stringent health standards and operational efficiency at the Minneapolis VA Medical Center, which serves as the sole national provider of drug testing for VA hospitals. The total award amount is capped at $1,000,000, with a contract duration from December 8, 2024, to September 30, 2025, and options for extensions through September 30, 2029. Interested vendors should direct inquiries to Contract Specialist Alisha L Milander at Alisha.Milander@va.gov, with proposals due by November 21, 2024.
    Navy Quad Test Kit With Probe
    Active
    Dept Of Defense
    The Department of the Navy, through the Naval Undersea Warfare Center Division Newport (NUWCDIVNPT), is seeking quotes for the procurement of two units of the Navy Quad Test Kit with Probe, specifically the KITCO brand, as part of Request for Quote (RFQ) Number N66604-24-Q-0775. This procurement is exclusively set aside for small businesses and requires that the test kits meet specific military standards, including the prohibition of Bluetooth or Wi-Fi capabilities. The equipment is critical for Electronic Warfare Fiber Optic testing, ensuring compliance with operational requirements. Quotes are due by November 20, 2024, at 2:00 PM EST, and will be evaluated based on the Lowest Priced Technically Acceptable (LPTA) criteria. Interested contractors must register with the System for Award Management (SAM) and can direct inquiries to Kenneth Chaffey at kenneth.l.chaffey.civ@us.navy.mil or by phone at 14018321837.
    Medical Reagents for USNH Okinawa
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support is seeking qualified vendors to provide medical reagents and consumables for the United States Naval Hospital (USNH) in Okinawa, Japan. This procurement involves an Indefinite Delivery, Indefinite Quantity (ID/IQ) contract for laboratory supplies necessary for the operation of VITROS 7600 Immuno Analyzers, with a focus on ensuring compatibility and compliance with existing medical equipment. The estimated contract value is approximately $5 million, and interested parties must submit their quotes in Japanese Yen by November 29, 2024, at 08:00 am Japan Standard Time (JST). For further inquiries, vendors can contact Bradley Ah Nee at bradley.ahnee@dla.mil or Kirk Moser at Kirk.Moser@dla.mil.
    CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is planning to issue a sole source award contract to Roche Diagnostics Corporation for the Chemistry and Immunoassay Testing Program. This program is intended to sustain the use of three Chemistry and Immunochemistry Systems under a Cost Per Reportable Result (CPRR) agreement or Cost Per Reagent Pack. The program includes equipment, reagents, tools, materials, training, and a water purification system, Uninterruptible Power Supply (UPS), and services necessary to meet the Chemistry and Immunochemistry testing and analysis requirements for Walter Reed National Military Medical Center (WRNMMC) laboratories. The anticipated period of performance is five years.
    Roche Cobas 6000 Reagents, Consumables and Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking qualified contractors to provide Roche Cobas® 6000 reagents, consumables, and preventative maintenance services for its Clinical Center's Department of Laboratory Medicine. The procurement aims to ensure the continued operation of the Roche Cobas 6000 system, which is critical for performing a wide range of chemistry and immunoassay tests necessary for patient care and research protocols. This system requires proprietary Roche products, and the selected contractor will be responsible for delivering reagents and consumables as needed, along with maintenance services performed by authorized technicians. Interested parties must submit their responses, including company information and capability statements, to Sheri Eiri at sheri.eiri@nih.gov by 12:00 PM EST on November 28, 2024. The anticipated period of performance for this contract is from February 1, 2025, to January 31, 2026.
    Sources Sought: Decontamination Kit (NSN: 4230-00-162-6538)
    Active
    Dept Of Defense
    The Department of Defense, specifically the Army Contracting Command - Detroit Arsenal (ACC-DTA), is seeking information from potential vendors regarding their capabilities to produce a Decontamination Kit (NSN: 4230-01-627-6538, Part No. 1375-507). This procurement is part of the Joint Biological Point Detection System, and the ACC-DTA is interested in understanding the qualifications and manufacturing capacities of both small and large businesses. Responses to this Sources Sought Notice will assist in planning for a potential contract, although no solicitation or contract award is guaranteed. Interested parties must submit their responses, including relevant documentation, by 4:30 P.M. EST on November 26, 2024, to Eboni Albert at eboni.q.albert.civ@army.mil, ensuring adherence to confidentiality guidelines regarding proprietary information.
    6550--580-25-2-026-0032 Reagents for BioFire Analyzer (VA-25-00011404)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking vendors to provide reagents for the BioFire Analyzer at the Michael E. DeBakey VA Medical Center in Houston, Texas. This Sources Sought Notice aims to identify potential sources to inform the procurement strategy for a forthcoming solicitation, which includes specific reagents and quantities necessary for diagnostic purposes. The anticipated contract will be a Single Award, Firm Fixed Price with a one-year ordering period, and responses are encouraged from both small and large businesses, particularly those compliant with the Non-Manufacturer Rule and authorized distributors of OEM parts. Interested parties must submit their responses, including market pricing estimates, by November 29, 2024, to Contracting Officer Shasta Britt at shasta.britt@va.gov.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotations for pharmaceutical agents to be included in the Uniform Formulary (UF) as part of its pharmacy benefits program for the Military Health System (MHS). This procurement aims to establish Blanket Purchase Agreements (BPAs) and Additional Discount Programs (ADPs) for cost-effective pharmaceutical options, ensuring that the selected agents meet clinical and cost-effectiveness criteria as evaluated by the Pharmacy and Therapeutics (P&T) Committee. The initiative is critical for providing safe and effective medications to military beneficiaries while managing costs within the healthcare system. Interested manufacturers must submit their quotes by December 30, 2024, and can direct inquiries to Tracy Banks or Keith Marasigan via their respective emails for further information.
    6640--VA Central California Health Care System Chemistry & Immunoassay CPRR Equipment and Tests
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified contractors to provide clinical laboratory analyzer equipment for Chemistry and Immunoassay testing on a Cost Per Reportable Result (CPRR) basis for the VA Central California Health Care System. This procurement involves a five-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract, which will span from April 2025 to September 2029, and includes specific ordering periods for various laboratory tests and equipment. The initiative is crucial for enhancing diagnostic capabilities and ensuring high-quality healthcare services for veterans, with a focus on automation, reliability, and compliance with federal regulations. Interested parties can contact Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov or David J. Alvarez at david.alvarez4@va.gov for further details regarding the solicitation, identified as 36C26125Q0065.
    6630--V16 Lab Chemistry and Immunochemistry CPRR BPA (VA-25-00010416)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for a Blanket Purchase Agreement (BPA) focused on Chemistry and Immunochemistry instrumentation and testing for the South Central VA Health Care Network (VISN 16). This procurement aims to standardize automated equipment across 8 medical center and 20 outpatient laboratories, ensuring compliance with the 1988 Clinical Laboratory Improvement Act and FDA approval for all reagents, while also providing operator training and 24/7 repair services. The initiative underscores the VA's commitment to enhancing laboratory capabilities through modern technology, with site visits permitted until February 28, 2025, allowing vendors to assess laboratory conditions and align their offerings with specific site requirements. Interested contractors can contact Diyonne Williams, the Contracting Officer, at Diyonne.Williams@va.gov for further information.